SBI Holdings Inc
TSE:8473
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 884.5
4 226
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
SBI Holdings Inc
SBI Holdings Inc
Investor Relations
SBI Holdings Inc., originally a financial services arm of the SoftBank Group, has transformed itself into a formidable independent entity, pioneering the digital finance landscape in Japan and beyond. Established in 1999, the company embarked on a mission to revolutionize traditional banking and investment services by embracing the burgeoning opportunities presented by the internet and technology. At its core, SBI Holdings leverages its diverse fintech ecosystem, spanning asset management, banking, and securities, to seamlessly integrate these services into a cohesive model. Its approach is underpinned by strategic partnerships and investments across global ventures, manifesting in a robust portfolio that includes ventures in AI, blockchain, and cryptocurrency. By doing so, the company skillfully navigates the intersection of finance and innovation, continually setting benchmarks for the industry.
What truly distinguishes SBI Holdings is its dynamic revenue generation model, rooted in diversification. It achieves this by maintaining a flexible yet comprehensive approach to its three principal business segments: Financial Services, Asset Management, and Biotechnology-Related Business. Through its financial services division, SBI Holdings earns substantial income from traditional banking services, brokerages, and insurance, efficiently utilizing digital platforms to reach a broad customer base. The Asset Management arm thrives by managing investment funds, private equity, and the intricate world of venture capital, capitalizing on emerging tech companies. Interestingly, its Biotechnology segment is a strategic exploration into the promising future of life sciences, highlighting its intention to capitalize on health innovations. This blended business model allows SBI to harness varied revenue streams while creating synergy between technology and finance, propelling it toward sustainable growth and innovation-driven success.
SBI Holdings Inc., originally a financial services arm of the SoftBank Group, has transformed itself into a formidable independent entity, pioneering the digital finance landscape in Japan and beyond. Established in 1999, the company embarked on a mission to revolutionize traditional banking and investment services by embracing the burgeoning opportunities presented by the internet and technology. At its core, SBI Holdings leverages its diverse fintech ecosystem, spanning asset management, banking, and securities, to seamlessly integrate these services into a cohesive model. Its approach is underpinned by strategic partnerships and investments across global ventures, manifesting in a robust portfolio that includes ventures in AI, blockchain, and cryptocurrency. By doing so, the company skillfully navigates the intersection of finance and innovation, continually setting benchmarks for the industry.
What truly distinguishes SBI Holdings is its dynamic revenue generation model, rooted in diversification. It achieves this by maintaining a flexible yet comprehensive approach to its three principal business segments: Financial Services, Asset Management, and Biotechnology-Related Business. Through its financial services division, SBI Holdings earns substantial income from traditional banking services, brokerages, and insurance, efficiently utilizing digital platforms to reach a broad customer base. The Asset Management arm thrives by managing investment funds, private equity, and the intricate world of venture capital, capitalizing on emerging tech companies. Interestingly, its Biotechnology segment is a strategic exploration into the promising future of life sciences, highlighting its intention to capitalize on health innovations. This blended business model allows SBI to harness varied revenue streams while creating synergy between technology and finance, propelling it toward sustainable growth and innovation-driven success.
You don't have any saved screeners yet
